临床试验/ISRCTN16757172

ISRCTN16757172已完成未知

KALL XI (92) - Acute lymphoblastic leukaemia trial

Medical Research Council (MRC) (UK)0 个研究点目标入组 2,090 人开始时间: 2000年10月25日最近更新: 2022年9月12日

适应症

试验速览

阶段: 未知
状态: 已完成
发起方
入组人数: 2,090

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

2001 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/11328289 2002 Results article in http://www.ncbi.nlm.nih.gov/pubmed/11813173 2004 Results article in http://www.ncbi.nlm.nih.gov/pubmed/14675406 2011 Results article in https://pubmed.ncbi.nlm.nih.gov/21996369/ (added 01/09/2022)

研究设计

研究类型: Interventional

入排标准

性别: All

入选标准

•They are children including those with Down's syndrome or leukaemia associated chromosome translocations over 1 year and under 15 years with newly diagnosed ALL of any immunologic subtype except B-A

排除标准

•Children with B-ALL and those under 1 year

研究者

发起方

Medical Research Council (MRC) (UK)

相似试验

Acute lymphoblastic leukaemia (ALL) trial XII (joint trial with Eastern Co-operative Oncology Group - E2993)eukaemiaCancerLeukaemia

ISRCTN77346223Medical Research Council (MRC) (UK)550

KALL R2 - Acute Lymphoblastic Leukaemia trialAcute Lymphoblastic LeukaemiaCancer

ISRCTN95257778Medical Research Council (MRC) (UK)200

Acute Myeloid Leukaemia (AML) Trial 12 (modified) for patients aged under 60eukaemia (acute)LeukaemiaCancer

ISRCTN55678797Medical Research Council (MRC) (UK)500

Acute myeloid leukaemia (AML) trial 12 (protocol for children)eukaemiaLeukaemiaCancer

ISRCTN64649191Medical Research Council (MRC) (UK)2,000

Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/LymphomaLymphoblastic LeukemiaLymphoblastic Lymphoma

NCT03328104Emory University8